当前位置:首页 - 行情中心 - 明德生物(002932) - 财务分析

明德生物

(002932)

  

流通市值:30.34亿  总市值:45.20亿
流通股本:1.56亿   总股本:2.33亿

明德生物(002932)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.03亿元,每股收益-0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益599966.90万元,未分配利润437373.44万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产649940.21万元,负债49973.30万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入69,960,271.6350,061,800.61225,617,843.38154,270,388.52
营业总成本114,191,703.22432,523,176.2319,893,245.81212,168,994.95
营业利润-2,427,213.4841,186,901.8982,281,071.7770,107,733.62
利润总额-3,969,638.7832,415,968.4278,074,642.867,715,284.56
净利润-3,405,173.9926,564,716.4962,363,772.1654,771,533.94
其他综合收益----
综合收益总额-3,405,173.9926,564,716.4962,363,772.1654,771,533.94
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计4,306,916,741.272,397,670,406.852,120,880,457.632,384,054,743.91
非流动资产合计2,192,485,320.364,195,408,189.054,709,060,724.794,549,367,260.12
资产总计6,499,402,061.636,593,078,595.96,829,941,182.426,933,422,004.03
流动负债合计421,478,788.73495,856,537.68645,171,910.76730,859,846.12
非流动负债合计78,254,258.3878,544,618.274,447,114.7573,908,927.03
负债合计499,733,047.11574,401,155.88719,619,025.51804,768,773.15
归属于母公司股东权益合计5,807,125,824.335,826,392,063.95,888,448,333.175,898,595,850.24
股东权益合计5,999,669,014.526,018,677,440.026,110,322,156.916,128,653,230.88
负债和股东权益合计6,499,402,061.636,593,078,595.96,829,941,182.426,933,422,004.03
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计154,356,495.64946,613,595.02689,598,336.84487,937,057.78
经营活动现金流出小计184,880,983.971,031,660,034.59812,864,780.68645,892,120.69
经营活动产生的现金流量净额-30,524,488.33-85,046,439.57-123,266,443.84-157,955,062.91
投资活动现金流入小计31,992,423.78772,300,848.49423,910,028.25303,251,790.75
投资活动现金流出小计127,015,255.12910,425,484.33568,653,644.73319,328,765.78
投资活动产生的现金流量净额-95,022,831.34-138,124,635.84-144,743,616.48-16,076,975.03
筹资活动现金流入小计-21,876,745.9900
筹资活动现金流出小计15,635,616.79335,045,214.85250,643,991.1263,137,043.5
筹资活动产生的现金流量净额-15,635,616.79-313,168,468.86-250,643,991.12-63,137,043.5
汇率变动对现金及现金等价物的影响-37,577.57506,232.79-1,049,547.18-63,352.87
现金及现金等价物净增加额-141,220,514.03-535,833,311.48-519,703,598.62-237,232,434.31
期末现金及现金等价物余额236,986,049.47378,206,563.5394,336,276.36676,807,440.67
TOP↑